Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZANIDATAMAB vs ZANUBRUTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ZANIDATAMAB vs ZANUBRUTINIB: Safety Overview

Metric ZANIDATAMAB ZANUBRUTINIB
Total FAERS Reports 142 2,797
Deaths Reported 12 320
Death Rate 8.5% 11.4%
Hospitalizations 125 806
Average Patient Age 65.2 yrs 71.5 yrs
% Female Patients 40.2% 43.0%
FDA Approval Date N/A Jun 10, 2025
Manufacturer Jazz Pharmaceuticals, Inc. BeOne Medicines USA, Inc.
Route INTRAVENOUS ORAL
Marketing Status N/A Discontinued